Innovation is a competitive advantage for European companies, which is essential to go along with the ecological transition, revitalise the economy, and ensure the well-being of citizens. The EU's anti-crisis strategies aim to strengthen autonomy in key high-innovation sectors such as pharma, which employed 840,000 people in 2021 and recorded a production value of €300 billion. "As well as driving…